The World Health Organization (WHO) released its first-ever guideline on using GLP-1 medications to treat obesity. The disease now affects more than 1 billion people worldwide and is tied to 3.7 ...

A new study has found that soybean oil contributed to obesity in mice, prompting concern that the United States' most popular cooking oil could be playing a role in the country's obesity problem. The ...

The Trump administration is making a significant effort to reduce the cost of weight loss drugs. Its agreement with pharmaceutical giants, announced Nov. 6, will reduce the monthly prices of these ...

WASHINGTON -- Part of America's obesity problem comes from people not recognizing how precious their own lives are, Mehmet Oz, MD, MBA, administrator of CMS, said on Monday. "Most people that I talk ...

As more Americans turn to weight loss drugs, the U.S. adult obesity rate is declining, according to new survey data from Gallup. The data published Tuesday showed the obesity rate among participants ...

Withings Health Solutions, a company offering health monitoring devices, has added Ilant Health to its Obesity Care Management Partner Ecosystem. It also released its best practices for obesity ...

The MarketWatch News Department was not involved in the creation of this content. Dover, DE, Oct. 14, 2025 (GLOBE NEWSWIRE) -- In a major step forward for obesity solutions, Fuzzle, a pioneering ...

LONDON, Sept 15 (Reuters) - The World Health Organization will recommend using weight-loss drugs to treat obesity in adults, according to draft guidance from the agency that urged countries to take ...

Consider someone who’s perfectly content with their office chair. It’s not ergonomic, it doesn’t have lumbar support, but it works. Then, during a meeting or a visit to a friend’s office, they sit in ...

Obesity is a major health problem facing our country. According to the CDC, more than 40 percent of the U.S. population is obese, defined as having a body-mass index above 30. As astounding at that ...

That overweight person you’re judging might not be able to control the amount they eat. For ten years, Joshua Bell was part of a team that researched the causes and incidence of obesity in Britain.

Pfizer halted its oral obesity drug, danuglipron, in April 2025 due to liver injury concerns, a major pipeline setback. The $100 billion obesity market is dominated by injectables, but oral solutions ...